OpenEvidence raised $250m at $15bn and says it will now try to make cancer drugs itself
Four years after launching a search tool for doctors, the Miami company says the data flowing through it is the basis for its own oncology pipeline.
Company
OpenEvidence is an organisation working in artificial intelligence, founded in 2022 and based in Miami, Florida, United States. This page collects every Aivio News story about OpenEvidence, together with its models and recorded benchmark results.
OpenEvidence raised $250m at $15bn and says it will now try to make cancer drugs itself
Four years after launching a search tool for doctors, the Miami company says the data flowing through it is the basis for its own oncology pipeline.
Privacy preferences
We use necessary cookies to run this site. With your consent we also use advertising cookies. You can change your choice at any time. Cookie Policy · Privacy Policy